Johnson & Johnson (JNJ)

144.54 -0.23 (-0.16%) USD  |  NYSE  |  Apr 18, 14:32
More

Johnson & Johnson Research and Development Expense (Quarterly): 4.48B for Dec. 31, 2023

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1994. Upgrade now.
Date Value
December 31, 2023 4.48B
September 30, 2023 3.447B
June 30, 2023 3.829B
March 31, 2023 3.612B
December 31, 2022 3.71B
September 30, 2022 3.485B
June 30, 2022 3.703B
March 31, 2022 4.072B
December 31, 2021 4.283B
September 30, 2021 3.422B
June 30, 2021 3.394B
March 31, 2021 3.178B
December 31, 2020 4.213B
September 30, 2020 2.84B
June 30, 2020 2.707B
March 31, 2020 2.58B
December 31, 2019 3.232B
September 30, 2019 2.599B
June 30, 2019 2.666B
March 31, 2019 2.858B
December 31, 2018 3.224B
September 30, 2018 2.508B
June 30, 2018 2.639B
March 31, 2018 2.404B
December 31, 2017 3.643B
Date Value
September 30, 2017 2.585B
June 30, 2017 2.296B
March 31, 2017 2.07B
December 31, 2016 2.688B
September 30, 2016 2.178B
June 30, 2016 2.264B
March 31, 2016 2.013B
December 31, 2015 2.864B
September 30, 2015 2.154B
June 30, 2015 2.129B
March 31, 2015 1.899B
December 31, 2014 2.635B
September 30, 2014 2.023B
June 30, 2014 2.005B
March 31, 2014 1.831B
December 31, 2013 2.411B
September 30, 2013 2.042B
June 30, 2013 1.946B
March 31, 2013 1.784B
December 31, 2012 2.331B
September 30, 2012 1.923B
June 30, 2012 1.766B
March 31, 2012 1.645B
December 31, 2011 2.155B
September 30, 2011 1.773B

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

2.58B
Minimum
Mar 2020
4.48B
Maximum
Dec 2023
3.445B
Average
3.447B
Median
Sep 2023

Research and Development Expense (Quarterly) Benchmarks

Amgen Inc 1.534B
Gilead Sciences Inc 1.408B
Eli Lilly and Co 2.563B
Merck & Co Inc 9.627B
Shockwave Medical Inc 42.32M